/HESG

HESG Stock - Health Sciences Group, Inc.

Q: What is the analyst price target for HESG?

Analyst price target information is not currently available for HESG.

Q: What is HESG's market cap?

Market capitalization information is not currently available for HESG.

Healthcare|Biotechnology|OTC

$0.00+0.00%

+$0.00 (+0.00%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

100

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.00

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for HESG

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2002

FY2003

FY2004

FY2005

FY2012

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta-41.56

52W High$0.00

52W Low$0.00

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2012	FY2005	FY2004	FY2003	FY2002
Revenue	$358,434	$60,142	$67,204	$5.37M	$5.54M
Gross Profit	$25,228	$22,913	$46,665	$998,479	$1.49M
Gross Margin	7.0%	38.1%	69.4%	18.6%	26.9%
Operating Income	$-54,487	$-7,482,000	$-4,547,000	$-3,803,000	$-4,080,000
Net Income	$-54,487	$-5,750,000	$-10,452,000	$-7,419,000	$-4,284,000
Net Margin	-15.2%	-9560.7%	-15552.6%	-138.3%	-77.4%
EPS	$-0.03	$-0.25	$-0.78	$-0.76	$-0.73

Company Overview

Health Sciences Group Inc., through its subsidiaries, provides various products used in nutritional supplements and functional foods and beverages in the United States. It primarily offers Shugr, a zero-calorie sugar substitute that tastes and bakes like cane sugar; and Sequesterol Advance Cardio Formula, a proprietary blend of clinically studied ingredients for the maintenance of cardiovascular health and a free-flowing circulatory system. The company also offers Aplevia, an antioxidant derived from apple peels; and Edible Sponges, an open-cell hydrocolloid product. It sells its products primarily through mass market retailers, such as mass merchandisers, drug stores, supermarkets, and discount stores, as well as through healthcare professionals and practitioners, and other media. Health Sciences Group was founded in 1996 as Centurion Properties Development Corporation and changed its name to iGoHealthy.com in 2000. It changed its name to Health Sciences Group, Inc. in 2001. The company is based in Newport Beach, California.

Frequently Asked Questions about HESG

What is HESG's current stock price?

Health Sciences Group, Inc. (HESG) is currently trading at $0.00 per share. The stock has moved +0.00% today.

What is the analyst price target for HESG?

No analyst price targets are currently available for this stock.

What sector is Health Sciences Group, Inc. in?

Health Sciences Group, Inc. operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the OTC exchange.

What is HESG's market cap?

Health Sciences Group, Inc. has a market capitalization of $0.00 billion, making it a small-cap company.

Does HESG pay dividends?

No, Health Sciences Group, Inc. does not currently pay a dividend to shareholders.